It is a pharma private limited company based in Bhopal, Madhya Pradesh, India, established in 2014.
2014 | Bhopal, Madhya Pradesh, India | ActiveAnanjay Pharmaceuticals Private Limited, a active private limited company, was established on 02 December 2014 in Bhopal, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MP2014PTC033507. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Anupam Chouksey (Director), Dharmendra Shivhare Kumar (Director). Past directors included Dharmendra Shivhare Kumar, Virat Jaiswal. It holds no open charges and ₹10.91 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H No-31, Shyamla Road Shyamla Hills, Bhopal, Madhya Pradesh, 462001.
U24232MP2014PTC033507
033507
02 December 2014
₹1.00 M
₹1.00 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Ananjay Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anupam Chouksey | Director | 02 Dec 2014 | Current |
| Dharmendra Shivhare Kumar | Director | 28 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 28 Jan 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ananjay Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 48.49% decrease. The company also saw a slight decrease in profitability, with a 3.59% decrease in profit. The company's net worth Soared by an impressive increase of 12.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Ananjay Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹109,057,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Feb 2021 | Others | ₹1.16 Cr | Satisfied |
| 09 Apr 2019 | Others | ₹9.75 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ananjay Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ananjay Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ananjay Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ananjay Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Ananjay Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.
The activity A charge registered on 16 Feb 2021 via Charge ID 100422316 with Others was fully satisfied on 28 Jun 2023. was completed.
The activity A charge registered on 09 Apr 2019 via Charge ID 100254743 with Others was fully satisfied on 28 Jun 2023. was completed.
Progress on A charge with Others amounted to Rs. 11.56 M with Charge ID 100422316 was registered on 16 Feb 2021. was documented.
A charge with Others of Rs. 97.50 M registered on 09 Apr 2019 with Charge ID 100254743 was modified on 06 Feb 2020. was recorded as a recent event.
The CIN of Ananjay Pharmaceuticals Private Limited is U24232MP2014PTC033507.
Ananjay Pharmaceuticals Private Limited is headquartered at H No-31, Shyamla Road Shyamla Hills, Bhopal, Madhya Pradesh, 462001.
Ananjay Pharmaceuticals Private Limited was incorporated on 02 December 2014.
The current directors of Ananjay Pharmaceuticals Private Limited are
The primary industry of Ananjay Pharmaceuticals Private Limited is Manufacturing.
Ananjay Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ananjay Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Ananjay Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX